[1] Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA Cancer J Clin,2011, 61(2):69-90.
[2] Hundahl SA, Fleming ID, Fremgen AM, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [J]. Cancer,1998, 83(12):2638-2648.
[3] Elaraj DM, Sturgeon C. Adequate surgery for papillary thyroid cancer[J]. Surgeon,2009, 7(5):286-289.
[4] Carling T, Udelsman R. Thyroid cancer [J]. Annu Rev Med,2014, 65:125-137.
[5] Nixon IJ, Ganly I, Shah JP. Thyroid cancer:surgery for the primary tumor [J]. Oral Oncol,2013, 49(7):654-658.
[6] Sakorafas GH, Sampanis D, Safioleas M. Cervical lymph node dissection in papillary thyroid cancer:current trends, persisting controversies, and unclarified uncertainties [J]. Surg Oncol,2010, 19(2):e57-70.
[7] Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002 [J]. JAMA, 2006, 295(18):2164-2167.
[8] Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer [J]. Ann Surg 2007, 246(3):375-381.
[9] Shindo M, Wu JC, Park EE, et al. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer [J]. Arch Otolaryngol Head Neck Surg,2006, 132(6):650-654.
[10] Ito Y, Jikuzono T, Higashiyama T, et al. Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe [J]. World J Surg, 2006, 30(10):1821-1828.
[11] Pereira JA, Jimeno J, Miquel J, et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma [J]. Surgery,2005, 138(6):1095-1100.
[12] Mazzaferri EL, Kloos RT. Clinical review 128:Current approaches to primary therapy for papillary and follicular thyroid cancer [J]. J Clin Endocrinol Metab,2001, 86(4):1447-1463.
[13] Harwood J, Clark OH, Dunphy JE. Significance of lymph node metastasis in differentiated thyroid cancer [J]. Am J Surg,1978, 136(1):107-112.
[14] Toniato A, Boschin I, Casara D, et al. Papillary thyroid carcinoma:factors influencing recurrence and survival [J]. Ann Surg Oncol,2008, 15(5):1518-1522.
[15] Sywak M, Pasieka JL, Ogilvie T. A review of thyroid cancer with intermediate differentiation [J]. J Surg Oncol, 2004, 86(1):44-54.
[16] Ye ZQ, Gu DN, Hu HY, et al. Hashimoto's thyroiditis, microcalcification and raised thyrotropin levels within normal range are associated with thyroid cancer [J]. World J Surg Oncol,2013, 11(1):1-7.
[17] Bai Y, Zhou G, Nakamura M, et al. Survival impact of psammoma body, stromal calcification, and bone formation in papillary thyroid carcinoma [J]. Mod Pathol, 2009, 22(7):887-894.
[18] Ito Y, Fukushima M, Kihara M, et al. Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size [J]. Endocr J,2012, 59(6):457-464.
[19] Liu X, Zhu L, Wang Z, et al. Evolutionary features of thyroid cancer in patients with thyroidectomies from 2008 to 2013 in China[J]. Sci Rep,2016, 6:28414. |